Company Filing History:
3 out of 3,223 
3 out of 84 
Years Active: 2005-2009
Title: David A. Lewin: Innovator in Cytokine-Like Polypeptides
Introduction
David A. Lewin is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides and their applications in medical science. With a total of 3 patents, Lewin's work has the potential to impact various pathological states.
Latest Patents
Among his latest patents is the invention of WNT-regulated cytokine-like polypeptides and the nucleic acids encoding them. This invention provides novel polypeptides, termed FCTRX polypeptides, along with polynucleotides that encode these polypeptides. Additionally, it includes antibodies that specifically bind to FCTRX or its derivatives, variants, mutants, or fragments. The invention outlines methods for using the FCTRX polypeptide, polynucleotide, and antibody in the detection and treatment of a wide range of pathological conditions.
Career Highlights
David A. Lewin has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Curagen Corporation. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.
Collaborations
Throughout his career, Lewin has collaborated with notable colleagues such as Diane Pennica and Luca Rastelli. These collaborations have likely enriched his research and development efforts.
Conclusion
David A. Lewin's contributions to the field of biotechnology, particularly through his patents on cytokine-like polypeptides, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to hold promise for future applications in healthcare.